Skip to main content
Figure 1 | BMC Infectious Diseases

Figure 1

From: A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections

Figure 1

Analysis population. Footnote: *Subjects could be excluded for more than 1 reason. ITT, intent-to-treat; mITT, modified intent-to-treat; TGC, tigecycline; Comp, comparator. c-mITT, clinical modified intent-to-treat; TOC, test-of-cure; m-mITT, microbiologic-modified intent-to-treat; CE, clinically evaluable; ME, microbiologically evaluable.

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us